Clinical Trial: A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942923) titled 'A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity' on April 17.

Brief Summary: The aim of this study is to evaluate the safety and tolerability, and pharmacodynamics (PD) of AZD4144 administered as repeated daily oral dosing.

Study Start Date: April 22

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD4144

AZD4144 will be administered orally as per arms they have been assigned.

DRUG: Placebo

Placebo will be administered orally as per arms they have been assigned.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaim...